IL6 is upregulated in the lower airways of patients with mild to moderate COPD (Sulaiman et al., 2023), and IL-6TS could play a pathogenic role in chronic respiratory diseases (Winslow et al., 2021). Here, IL6 is linked to chronic obstructive pulmonary disease.